Target Specific Uptake of a Newly Synthesized Radiolabeled 5α-Reductase Inhibitor "Tc-99m-17-Oxo-17a-Aza-D-Homo-5-Androsten-3β-yl Phenoxyacetate (Tc-99m-17a-Aza Steroid)" in Rat Prostatic Neoplastic Lesions.

MLA

Jan, Gowsia, et al. “Target Specific Uptake of a Newly Synthesized Radiolabeled 5α-Reductase Inhibitor ‘Tc-99m-17-Oxo-17a-Aza-D-Homo-5-Androsten-3β-Yl Phenoxyacetate (Tc-99m-17a-Aza Steroid)’ in Rat Prostatic Neoplastic Lesions.” Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India, vol. 37, no. 2, Apr. 2022, pp. 133–41. EBSCOhost, https://doi.org/10.4103/ijnm.ijnm_128_21.

APA

Jan, G., Bhat, S., Chauhan, M., Dhawan, D. K., Dhingra, N., & Chadha, V. D. (2022). Target Specific Uptake of a Newly Synthesized Radiolabeled 5α-Reductase Inhibitor “Tc-99m-17-Oxo-17a-Aza-D-Homo-5-Androsten-3β-yl Phenoxyacetate (Tc-99m-17a-Aza Steroid)” in Rat Prostatic Neoplastic Lesions. Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India, 37(2), 133–141. https://doi.org/10.4103/ijnm.ijnm_128_21

Chicago

Jan, Gowsia, Swati Bhat, Monika Chauhan, Devinder Kumar Dhawan, Neelima Dhingra, and Vijayta Dani Chadha. 2022. “Target Specific Uptake of a Newly Synthesized Radiolabeled 5α-Reductase Inhibitor ‘Tc-99m-17-Oxo-17a-Aza-D-Homo-5-Androsten-3β-Yl Phenoxyacetate (Tc-99m-17a-Aza Steroid)’ in Rat Prostatic Neoplastic Lesions.” Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India 37 (2): 133–41. doi:10.4103/ijnm.ijnm_128_21.